Yale Cancer Center investigators have demonstrated in a new study that more sophisticated models to assess patient risk for cancer can result in better clinical trials with more definitive results.
24-Jan-2018 2:25 PM EST Add to Favorites
Progress in treating lung cancer has been enormous in the past 20 years according to a new review by researchers at Yale Cancer Center.
22-Jan-2018 11:15 AM EST Add to Favorites
Yale Cancer Center (YCC) has been awarded a $1 million grant by the Bristol-Myers Squibb Foundation (BSMF) to address health care disparities in cancer care and support.
22-Jan-2018 3:40 PM EST Add to Favorites
According to Altmetric, which tracks the distribution and discussion of research papers online, a July article by several Yale physicians is the most-discussed paper ever published in the Journal of the National Cancer Institute (JNCI). The title of...
18-Jan-2018 3:05 PM EST Add to Favorites
New research by Yale Cancer Center (YCC) researchers shows a majority of pediatric cancer providers endorse the potential use of medical marijuana for children with advanced cancer, although providers who are legally eligible to certify its use are...
11-Dec-2017 12:00 AM EST Add to Favorites
With November Lung Cancer Awareness Month, experts from Yale Cancer Center talk about lung cancer screening and why it is can save lives.
1-Nov-2017 1:05 PM EDT Add to Favorites
Dr. Rogerio Lilenbaum, a board member of NCCN and Chief Medical Officer of Smilow Cancer Hospital at the Yale Cancer Center said that for nonsmall-cell lung cancer, both panel testing and liquid biopsies are appropriate.
11-Oct-2017 2:05 PM EDT Add to Favorites
Yale Cancer Center scientists now have made a fundamental discovery about EGFR signaling, reported in the journal Cell, that may open the potential for new types of cancer drugs.
11-Oct-2017 1:00 PM EDT Add to Favorites
see all news
For some cancer patients, the road to remission and healing can have its share of speed bumps. That’s particularly true of patients with non-small cell lung cancer (NSCLC) who develop a secondary, or acquired, resistance to immunotherapy, which...
27-Oct-2017 11:50 AM EDT
6-Oct-2017 3:05 PM EDT
6-Oct-2017 2:05 PM EDT
22-Sep-2017 4:30 PM EDT
22-Aug-2017 3:05 PM EDT
7-Jun-2017 10:20 AM EDT
1-Jun-2017 8:05 AM EDT
31-May-2017 11:05 AM EDTsee all experts